Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 92

    1.

    Proton NMR of (15)N-choline metabolites enhanced by dynamic nuclear polarization.

    Sarkar R, Comment A, Vasos PR, Jannin S, Gruetter R, Bodenhausen G, Hall H, Kirik D, Denisov VP.

    J Am Chem Soc. 2009 Nov 11;131(44):16014-5.PMID: 19848401 [PubMed - in process]Related articles

    2.

    Differential Transduction Following Basal Ganglia Administration of Distinct Pseudotyped AAV Capsid Serotypes in Nonhuman Primates.

    Dodiya HB, Bjorklund T, Stansell Iii J, Mandel RJ, Kirik D, Kordower JH.

    Mol Ther. 2009 Sep 22. [Epub ahead of print]PMID: 19773746 [PubMed - as supplied by publisher]Related articles

    3.

    Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats.

    Björklund T, Hall H, Breysse N, Soneson C, Carlsson T, Mandel RJ, Carta M, Kirik D.

    J Neurochem. 2009 Oct;111(2):355-67. Epub 2009 Aug 17.PMID: 19686242 [PubMed - indexed for MEDLINE]Related articles

    4.

    Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain.

    Thompson LH, Grealish S, Kirik D, Björklund A.

    Eur J Neurosci. 2009 Aug;30(4):625-38. Epub 2009 Aug 10.PMID: 19674082 [PubMed - indexed for MEDLINE]Related articles

    5.

    Dose optimization for long-term rAAV-mediated RNA interference in the nigrostriatal projection neurons.

    Ulusoy A, Sahin G, Björklund T, Aebischer P, Kirik D.

    Mol Ther. 2009 Sep;17(9):1574-84. Epub 2009 Jul 7.PMID: 19584816 [PubMed - indexed for MEDLINE]Related articles

    6.

    Huntington's disease - new perspectives based on neuroendocrine changes in rodent models.

    Petersén A, Hult S, Kirik D.

    Neurodegener Dis. 2009;6(4):154-64. Epub 2009 Jun 12. Review.PMID: 19521064 [PubMed - indexed for MEDLINE]Related articles

    7.

    Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model.

    Muñoz A, Carlsson T, Tronci E, Kirik D, Björklund A, Carta M.

    Exp Neurol. 2009 Sep;219(1):298-307. Epub 2009 Jun 3.PMID: 19500572 [PubMed - indexed for MEDLINE]Related articles

    8.

    Scientific rationale for the development of gene therapy strategies for Parkinson's disease.

    Björklund T, Kirik D.

    Biochim Biophys Acta. 2009 Jul;1792(7):703-13. Epub 2009 Feb 27. Review.PMID: 19254760 [PubMed - indexed for MEDLINE]Related articles

    9.

    Positron emission tomography imaging demonstrates correlation between behavioral recovery and correction of dopamine neurotransmission after gene therapy.

    Leriche L, Björklund T, Breysse N, Besret L, Grégoire MC, Carlsson T, Dollé F, Mandel RJ, Déglon N, Hantraye P, Kirik D.

    J Neurosci. 2009 Feb 4;29(5):1544-53.PMID: 19193901 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Applications of lentiviral vectors for biology and gene therapy of neurological disorders.

    Lundberg C, Björklund T, Carlsson T, Jakobsson J, Hantraye P, Déglon N, Kirik D.

    Curr Gene Ther. 2008 Dec;8(6):461-73. Review.PMID: 19075629 [PubMed - indexed for MEDLINE]Related articles

    11.

    Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.

    Carlsson T, Carta M, Muñoz A, Mattsson B, Winkler C, Kirik D, Björklund A.

    Brain. 2009 Feb;132(Pt 2):319-35. Epub 2008 Nov 27.PMID: 19039008 [PubMed - indexed for MEDLINE]Related articles

    12.

    Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.

    Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M.

    Brain. 2008 Dec;131(Pt 12):3380-94. Epub 2008 Oct 24.PMID: 18952677 [PubMed - indexed for MEDLINE]Related articles

    13.

    Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias.

    Carta M, Carlsson T, Muñoz A, Kirik D, Björklund A.

    Prog Brain Res. 2008;172:465-78. Review.PMID: 18772046 [PubMed - indexed for MEDLINE]Related articles

    14.

    Functional convergence of dopaminergic and cholinergic input is critical for hippocampus-dependent working memory.

    Wisman LA, Sahin G, Maingay M, Leanza G, Kirik D.

    J Neurosci. 2008 Jul 30;28(31):7797-807.PMID: 18667612 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Non-dopaminergic neurons in ventral mesencephalic transplants make widespread axonal connections in the host brain.

    Thompson LH, Kirik D, Björklund A.

    Exp Neurol. 2008 Sep;213(1):220-8. Epub 2008 Jun 17.PMID: 18602916 [PubMed - indexed for MEDLINE]Related articles

    16.

    Involvement of the serotonin system in L-dopa-induced dyskinesias.

    Carta M, Carlsson T, Muñoz A, Kirik D, Björklund A.

    Parkinsonism Relat Disord. 2008;14 Suppl 2:S154-8. Epub 2008 Jun 24. Review.PMID: 18579429 [PubMed - indexed for MEDLINE]Related articles

    17.

    Can overexpression of parkin provide a novel strategy for neuroprotection in Parkinson's disease?

    Ulusoy A, Kirik D.

    Exp Neurol. 2008 Aug;212(2):258-60. Epub 2008 May 3. Review.PMID: 18538324 [PubMed - indexed for MEDLINE]Related articles

    18.

    Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion.

    Nygren JM, Liuba K, Breitbach M, Stott S, Thorén L, Roell W, Geisen C, Sasse P, Kirik D, Björklund A, Nerlov C, Fleischmann BK, Jovinge S, Jacobsen SE.

    Nat Cell Biol. 2008 May;10(5):584-92. Epub 2008 Apr 20.PMID: 18425115 [PubMed - indexed for MEDLINE]Related articles

    19.

    In vivo gene delivery to proliferating cells in the striatum generated in response to a 6-hydroxydopamine lesion of the nigro-striatal dopamine pathway.

    Irvin DK, Kirik D, Björklund A, Thompson LH.

    Neurobiol Dis. 2008 Jun;30(3):343-52. Epub 2008 Mar 4.PMID: 18417351 [PubMed - indexed for MEDLINE]Related articles

    20.

    Is alpha-synuclein the culprit of the Parkinsonian neurodegeneration?

    Kirik D, Gai WP, Jensen PH.

    Exp Neurol. 2008 Jan;209(1):3-4. No abstract available. PMID: 18179907 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...